XBI vs. ARTY

Last updated Jun 12, 2026

XBI (SPDR S&P Biotech ETF) and ARTY (iShares Future AI & Tech ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while ARTY is a Technology Equities fund tracking the Morningstar Global Artificial Intelligence Select Index (Net). Both are passively managed. Over the past 5 years, XBI returned -0.35%/yr vs 11.73%/yr for ARTY. A 0.61 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.47%/yr for ARTY.

Performance

XBI vs. ARTY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Biotech ETF (XBI) and iShares Future AI & Tech ETF (ARTY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XBI achieves a 8.87% return, which is significantly lower than ARTY's 50.46% return.

XBI

• 1D: 3.02%
• 1M: -1.61%
• YTD: 8.87%
• 6M: 8.26%
• 1Y: 57.91%
• 3Y*: 14.63%
• 5Y*: -0.35%
• 10Y*: 9.42%

ARTY

• 1D: 5.70%
• 1M: 8.32%
• YTD: 50.46%
• 6M: 45.65%
• 1Y: 88.63%
• 3Y*: 31.08%
• 5Y*: 11.73%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XBI vs. ARTY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
XBI SPDR S&P Biotech ETF	8.87%	35.89%	1.01%	7.60%	-25.87%	-20.45%	48.33%	32.56%	-23.29%
ARTY iShares Future AI & Tech ETF	50.46%	29.97%	8.02%	36.37%	-37.89%	6.32%	48.85%	34.47%	-13.76%

Correlation

The correlation between XBI and ARTY is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.40
Correlation (3Y) Calculated over the trailing 3-year period	0.50
Correlation (5Y) Calculated over the trailing 5-year period	0.58
Correlation (All Time) Calculated using the full available price history since Jun 28, 2018	0.61

Over the past year, the correlation between XBI and ARTY has dropped to 0.40 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.

XBI vs. ARTY - Sectors Allocation Comparison

Sectors	XBI	ARTY
Healthcare	99.8%	0.6%
Financial Services	0.2%	-
Basic Materials	0.2%	-
Communication Services	-	3.5%
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	5.3%
Real Estate	-	1.2%
Technology	-	87.7%
Utilities	-	1.7%

Return for Risk

XBI vs. ARTY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBI

XBI Risk / Return Rank: 85
XBI Sharpe Ratio Rank: 83
XBI Sortino Ratio Rank: 82
XBI Omega Ratio Rank: 74
XBI Calmar Ratio Rank: 94
XBI Martin Ratio Rank: 90

ARTY

ARTY Risk / Return Rank: 87
ARTY Sharpe Ratio Rank: 92
ARTY Sortino Ratio Rank: 83
ARTY Omega Ratio Rank: 84
ARTY Calmar Ratio Rank: 90
ARTY Martin Ratio Rank: 87

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBI vs. ARTY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and iShares Future AI & Tech ETF (ARTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XBI	ARTY	Difference
Sharpe ratio: Return per unit of total volatility	2.23	2.71	-0.47
Sortino ratio: Return per unit of downside risk	3.06	3.07	-0.01
Omega ratio: Gain probability vs. loss probability	1.36	1.42	-0.06
Calmar ratio: Return relative to maximum drawdown	5.99	4.74	+1.25
Martin ratio: Return relative to average drawdown	17.65	15.74	+1.91

XBI vs. ARTY - Sharpe Ratio Comparison

The current XBI Sharpe Ratio is 2.23, which is comparable to the ARTY Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of XBI and ARTY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XBI vs. ARTY - Drawdown Comparison

The maximum XBI drawdown since its inception was -63.89%, which is greater than ARTY's maximum drawdown of -54.50%. Use the drawdown chart below to compare losses from any high point for XBI and ARTY.

Drawdown Indicators

	XBI	ARTY	Difference
Max Drawdown Largest peak-to-trough decline	-63.89%	-54.50%	-9.39%
Max Drawdown (1Y) Largest decline over 1 year	-9.72%	-18.81%	+9.09%
Max Drawdown (3Y) Largest decline over 3 years	-32.99%	-32.44%	-0.55%
Max Drawdown (5Y) Largest decline over 5 years	-54.71%	-50.53%	-4.18%
Max Drawdown (10Y) Largest decline over 10 years	-63.89%	—	—
Current Drawdown Current decline from peak	-23.28%	-10.23%	-13.05%
Average Drawdown Average peak-to-trough decline	-20.93%	-19.81%	-1.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.29%	5.65%	-2.36%

Volatility

XBI vs. ARTY - Volatility Comparison

The current volatility for SPDR S&P Biotech ETF (XBI) is 10.38%, while iShares Future AI & Tech ETF (ARTY) has a volatility of 17.81%. This indicates that XBI experiences smaller price fluctuations and is considered to be less risky than ARTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XBI	ARTY	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	17.81%	-7.43%
Volatility (6M) Calculated over the trailing 6-month period	20.76%	28.84%	-8.08%
Volatility (1Y) Calculated over the trailing 1-year period	26.12%	32.93%	-6.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.22%	29.23%	+2.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.01%	28.12%	+3.89%

XBI vs. ARTY - Expense Ratio Comparison

XBI has a 0.35% expense ratio, which is lower than ARTY's 0.47% expense ratio.

Dividends

XBI vs. ARTY - Dividend Comparison

XBI's dividend yield for the trailing twelve months is around 0.33%, while ARTY has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARTY iShares Future AI & Tech ETF	0.00%	0.00%	0.50%	0.88%	0.75%	2.41%	0.53%	0.69%	0.34%	0.00%	0.00%	0.00%
XBI SPDR S&P Biotech ETF	0.33%	0.37%	0.15%	0.02%	0.00%	0.04%	0.20%	0.00%	0.28%	0.24%	0.26%	0.61%

Frequently Asked Questions

Can I hold both XBI and ARTY in my portfolio?

XBI and ARTY have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XBI or ARTY?

ARTY has higher volatility (17.81%) compared to XBI (10.38%). In terms of maximum drawdown, XBI dropped -63.89% vs ARTY's -54.50%.

Which ETF is better, XBI or ARTY?

On 5-year performance, ARTY leads with 11.73% vs -0.35% for XBI. On fees, XBI is cheaper at 0.35% per year. On volatility, XBI has been the lower-risk option at 10.38%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, XBI or ARTY?

Over the 5-year period, ARTY has performed better with a 11.73% return vs -0.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, XBI or ARTY?

XBI is cheaper with a 0.35% expense ratio, compared with 0.47% for ARTY.

Which ETF pays a higher dividend yield, XBI or ARTY?

XBI has the higher dividend yield at 0.33%, compared with 0.00% for ARTY.

What is the main difference between XBI and ARTY?

XBI is categorized as Health & Biotech Equities, while ARTY is Technology Equities. XBI tracks S&P Biotechnology Select Industry Index, while ARTY tracks Morningstar Global Artificial Intelligence Select Index (Net). They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XBI and 0.47% for ARTY.

Which has better risk-adjusted returns?

ARTY currently has the higher Sharpe Ratio (2.71 vs 2.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.